吉利德科学盘前跌2.9% 因CVS暂缓将其新型HIV预防针剂纳入药物保险覆盖清单

美股速递
Aug 21

吉利德科学股价在盘前交易中下跌2.9%,此前有报道称CVS暂缓将该公司新型HIV预防针剂添加到药物保险覆盖清单中。这一消息对投资者情绪造成了影响,导致该生物技术公司股价在正式开盘前出现下滑。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10